Agilent Technologies Inc (A)
132.70
+0.26
(+0.20%)
USD |
NYSE |
Apr 19, 16:00
132.74
+0.03
(+0.02%)
After-Hours: 20:00
Agilent Technologies Cash from Operations (TTM): 1.961B for Jan. 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
January 31, 2024 | 1.961B |
October 31, 2023 | 1.772B |
July 31, 2023 | 1.704B |
April 30, 2023 | 1.468B |
January 31, 2023 | 1.353B |
October 31, 2022 | 1.312B |
July 31, 2022 | 1.305B |
April 30, 2022 | 1.313B |
January 31, 2022 | 1.502B |
October 31, 2021 | 1.485B |
July 31, 2021 | 1.421B |
April 30, 2021 | 1.377B |
January 31, 2021 | 1.218B |
October 31, 2020 | 921.00M |
July 31, 2020 | 858.00M |
April 30, 2020 | 810.00M |
January 31, 2020 | 749.00M |
October 31, 2019 | 1.021B |
July 31, 2019 | 1.079B |
April 30, 2019 | 1.034B |
January 31, 2019 | 1.085B |
October 31, 2018 | 1.087B |
July 31, 2018 | 1.003B |
April 30, 2018 | 1.034B |
January 31, 2018 | 988.00M |
Date | Value |
---|---|
October 31, 2017 | 889.00M |
July 31, 2017 | 835.00M |
April 30, 2017 | 801.00M |
January 31, 2017 | 798.00M |
October 31, 2016 | 793.00M |
July 31, 2016 | 800.00M |
April 30, 2016 | 714.00M |
January 31, 2016 | 643.00M |
October 31, 2015 | 512.00M |
July 31, 2015 | 455.00M |
April 30, 2015 | 375.00M |
January 31, 2015 | 517.00M |
October 31, 2014 | 731.00M |
July 31, 2014 | 924.00M |
April 30, 2014 | 1.111B |
January 31, 2014 | 1.101B |
October 31, 2013 | 1.152B |
July 31, 2013 | 1.26B |
April 30, 2013 | 1.285B |
January 31, 2013 | 1.323B |
October 31, 2012 | 1.228B |
July 31, 2012 | 1.253B |
April 30, 2012 | 1.265B |
January 31, 2012 | 1.29B |
October 31, 2011 | 1.26B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
749.00M
Minimum
Jan 2020
1.961B
Maximum
Jan 2024
1.283B
Average
1.312B
Median
Cash from Operations (TTM) Benchmarks
Bio-Rad Laboratories Inc | 374.94M |
Revvity Inc | 91.27M |
Bruker Corp | 350.10M |
Azenta Inc | 70.94M |
Harvard Bioscience Inc | 14.03M |